Skip to content

Effect of spirulina on Irritable bowel syndrome patients

Effect of spirulina platensis supplementation on quality of life, severity of disease and serum total antioxidant capacity (TAC), manoldialdehyde (MDA) and zonulin in constipation-predominant Irritable bowel syndrome patients (IBS)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20140208016529N8
Enrollment
60
Registered
2023-04-25
Start date
2023-06-06
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable bowel syndrome. Irritable bowel syndrome

Interventions

Intervention 1: Intervention group: The intervention group will receive two capsule of spirulina (containing 500 mg of spirulina platensis powder) daily after breakfast for 12 weeks. Intervention 2:

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Ages range of 18-50 years patients diagnosed with irritable bowel syndrome through ROME IV criteria by a gastroenterologist

Exclusion criteria

Exclusion criteria: Smoking Alcohol consumption Pregnancy or breastfeeding condition Taking antidepressants and anxiety medications. Taking antioxidant and omega-3 supplements in the last three months Kidney, liver, thyroid and parathyroid, heart disease, cancer and gastrointestinal diseases other than IBS

Design outcomes

Primary

MeasureTime frame
Quality of life. Timepoint: At baseline and after 12 weeks. Method of measurement: Irritable bowel syndrome-quality of life- 34 (IBS-QOL-34)questionnaire.;Disease severity. Timepoint: At baseline and after 12 weeks. Method of measurement: Irritable bowel syndrome syndrome severity scale(IBS-SSS) questionnaire.;Serum zonulin level. Timepoint: At baseline and after 12 weeks. Method of measurement: Eliza kit.

Secondary

MeasureTime frame
Total antioxidant capacity of serum. Timepoint: At baseline and after 12 weeks. Method of measurement: Colorimetric method.;Malonaldehyde. Timepoint: At baseline and after 12 weeks. Method of measurement: Colorimetric method.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad hassan entezari

Esfahan University of Medical Sciences

entezari@hlth.mui.ac.ir+98 31 3792 3172

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026